Skip to main content

Table 1 The characteristic of each involved study

From: Lympho-vascular invasion impacts the prognosis in breast-conserving surgery: a systematic review and meta-analysis

Study

Year

Country or Region

Study type

Number of patients

Median follow-up months

Subtype

Chemotherapya

Radiotherapyb

Outcomesc

Magee B [37]

1996

United Kingdom

Prospective

708

96

Not mentioned

No

Mixed

BR (LR)

Dinshaw KA [25]

2005

India

Retrospective

1022

53

All

Adjuvant

Yes

OS/DFS/LRR/DM/LR

Yoshida T [38]

2009

Japan

Retrospective

2243

64.7

All

Adjuvant

Mixed

DM

Yi O.V. [39]

2009

Korea

Retrospective

578

54.1

All

Mixed

Yes

LR

Lupe K [40]

2011

Canada

Retrospective

2264

62.4

All

Not mentioned

Yes

LR

Adkins FC [41]

2011

America

Retrospective

1325

62

TNBC

Adjuvant

Mixed

LRR

Freedman GM [42]

2012

Brazil

Prospective

1478

68

All

Mixed

Yes

OS

Mittendorf EA [43]

2013

America

Prospective

2983

94.8

All

Mixed

Yes

LRR

Perez CA [44]

2013

America

Retrospective

704

51

TNBC

Adjuvant

Mixed

OS/LRR/DM

Matsuda N [45]

2014

Japan

Retrospective

622

51

All

Neoadjuvant

Yes

LRR

Park JS [46]

2015

Korea

Retrospective

1071

114

All

Adjuvant

Mixed

DFS/BCSS (DSS)

Sopik V[47]

2015

Canada

Retrospective

1675

157.2

All

Mixed

Mixed

BCSS (DSS)/LR

Nichol AM[26]

2017

Canada

Retrospective

1034

151.2

HR + 

Not mentioned

Half patients received

OS/EFS

Lee BM[27]

2018

Korea

Retrospective

2206

73

All

Mixed

Yes

OS

Chen SY[28]

2018

China

Retrospective

1791

50.4

All

Adjuvant

Yes

OS/DFS/LRR/DM

  1. LR, Local recurrence; LRR, Local–regional recurrence; BR, Breast recurrence; DFS, Disease-free survival; BCSS, Breast cancer-specific survival; DSS, Disease-specific survival; DM, Distant metastases; OS, Overall survival; EFS, Event-free survival
  2. a Chemotherapy is according to standard therapy, "Adjuvant" represents the study that excludes the patients who received neoadjuvant chemotherapy, "Neoadjuvant" means the study only includes the patients who received neoadjuvant chemotherapy, "Mixed" means the study contains all the BCS patients. Notice: "Adjuvant" and "Mixed" contain the patients who didn't receive the chemotherapy
  3. b "Yes" for the radiotherapy represents that the study excludes the patients who didn't receive the radiotherapy or received the nonstandard radiotherapy, "Mixed" means the study contains all the BCS patients
  4. c According to the original articles, BR is equal to LR, BCSS is equal to DSS. Univariate analysis has been excluded